Drugaí incréitín

Cruthúnas trialach de réir druga, le sonraí faoi dhíscaoileadh a fhágann margaíocht go minic amach.

Established

Semaglutide

GLP-1 receptor agonist. Ozempic, Wegovy, Rybelsus

Established

Tirzepatide

Dual GIP / GLP-1 receptor agonist. Mounjaro, Zepbound

Established

Liraglutide

GLP-1 receptor agonist. Victoza, Saxenda

Established

Dulaglutide

GLP-1 receptor agonist. Trulicity

Léitheoireacht ghaolmhar

Fasting Evidence

Intermittent fasting, time-restricted eating and meal timing, judged on the trial data.

Metabolism Review

Energy expenditure, insulin resistance and metabolic adaptation, without the folklore.

Weight Loss Evidence

Diets, drugs, behaviour and maintenance — ranked by the strength of the evidence behind them.

Sleep Evidence

Sleep, circadian rhythm and the wearables that claim to measure both.

Taispeánadh an leathanach seo go huathoibríoch ó Bhéarla. Ní athraítear na tagairtí agus na huimhreacha. Léigh an t-údarás Béarla má léitear rud ar bith go neamhréireach. Léigh an t-údarás Béarla